Auranofin
Top View
- RHEUMATOID ARTHRITIS (ART) Effectiveness of Care HEDIS® Measure
- Arava® Utilization Management Criteria
- In Vitro Effectivity of Three Approved Drugs and Their Synergistic Interaction Against Leishmania Infantum
- Auranofin a Preliminary Review of Its Pharmacological Properties and Therapeutic Use in Rheumatoid Arthritis
- Supplementary File Methods
- Repurposing of Auranofin: Thioredoxin Reductase Remains a Primary Target of the Drug
- The FDA- Approved Gold Drug Auranofin Inhibits Novel Coronavirus (SARS
- Studies of the Effect of Metal Containing Drugs on Acute and Chronic Inflammation
- Effect of Auranofin on Plasma Fibronectin, C Reactive Protein, and Albumin Levels in Arthritic Rats
- The Use of Disease Modifying Antirheumatic Drugs In
- MYOCHRYSINE (Sodium Aurothiomalate) Is Indicated in the Treatment of Both Adult and Juvenile Rheumatoid Arthritis
- Has a Time to Talk About Cure of AIDS Arrived?
- List of Selected Drugs
- Effect of Two Gold Compounds on Lysosomes
- The FDA-Approved Gold Drug Auranofin Inhibits Novel Coronavirus
- Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis
- (EDL) and a Licensed Drugs List (LDL) for Afghanistan
- Systematic Review of Combination DMARD Therapy in Rheumatoid Arthritis Beusekom I. Van1, C. Maclean2, C.F. Allaart3, and F.C. Br